Fine tuning host responses in the face of infection: Emerging roles and clinical applications of host defence peptides

Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies

Volumn , Issue , 2010, Pages 195-220

  Mayer, Matthew L ^a   Easton, Donna M ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858064379     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (166)

1. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H. and Gudmundsson, G.H. (2000) The human antimicrobial and chemotactic peptides LL-37 and a-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
2. Amid, C., Rehaume, L.M., Brown, K.L., Gilbert, J.G., Dougan, G., Hancock, R.E. and Harrow, J. L. (2009) Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome. BMC Genomics 10, 606.
3. Andra, J., Gutsmann, T., Garidel, P. and Brandenburg, K. (2006) Invited review: mechanisms of endotoxin neutralization by synthetic cationic compounds. Journal of Endotoxin Research 12, 261-277.
4. Bals, R. and Wilson, J.M. (2003) Cathelicidins-a family of multifunctional antimicrobial peptides. Cellular and Molecular Life Sciences 60, 711-720.
5. Baroni, A., Donnarumma, G., Paoletti, I., Longanesi-Cattani, I., Bifulco, K., Tufano, M.A. and Carriero, M.V. (2009) Antimicrobial human β-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 30, 267-272.
6. Benincasa, M., Scocchi, M., Pacor, S., Tossi, A., Nobili, D., Basaglia, G., Busetti, M. and Gennaro, R. (2006) Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. Journal of Antimicrobial Chemotherapy 58, 950-959.
7. Botsios, C. (2005) Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmunity Reviews 4, 162-170.
8. Bowdish, D.M., Davidson, D.J., Lau, Y.E., Lee, K., Scott, M.G. and Hancock, R.E. (2005a) Impact of LL-37 on anti-infective immunity. Journal of Leukocyte Biology 77, 451-459.
9. Bowdish, D.M., Davidson, D.J., Scott, M.G. and Hancock, R.E. (2005b) Immunomodulatory activities of small host defense peptides. Antimicrobial Agents and Chemotherapy. 49, 1727-1732.
10. Braff, M.H., Zaiou, M., Fierer, J., Nizet, V. and Gallo, R.L. (2005) Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infection and Immunity 73, 6771-6781.
11. Brzoska, T., Luger, T.A., Maaser, C., Abels, C. and Böhm, M. (2008) a-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews 29, 581-602.
12. Buchau, A.S., Morizane, S., Trowbridge, J., Schauber, J., Kotol, P., Bui, J.D. and Gallo, R.L. (2010) The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. Journal of Immunology 184, 369-378.
13. Carretero, M., Escamez, M.J., Garcia, M., Duarte, B., Holguin, A., Retamosa, L., Jorcano, J.L., Rio, M.D. and Larcher, F. (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. Journal of Investigative Dermatology 128, 223-236.
14. Casanova, J. and Abel, L. (2005) Inborn errors of immunity to infection: the rule rather than the exception. Journal of Experimental Medicine 202, 197-201.
15. Ceraudo, E., Murail, S., Tan, Y., Lacapère, J., Neumann, J., Couvineau, A. and Laburthe, M. (2008) The vasoactive intestinal peptide (VIP) a-helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/ pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics. Molecular Endocrinology 22, 147-155.
16. Cherkasov, A., Hilpert, K., Jenssen, H., Fjell, C.D., Waldbrook, M., Mullaly, S.C., Volkmer, R. and Hancock, R.E. (2009) Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibioticresistant superbugs. ACS Chemical Biology 4, 65-74.
17. Chorny, A. and Delgado, M. (2008) Neuropeptides rescue mice from lethal sepsis by downregulating secretion of the late-acting inflammatory mediator high mobility group box 1. American Journal of Pathology 172, 1297-1307.
18. Chorny, A., Aanderson, P., Gonzalez-Rey, E. and Delgado, M. (2008) Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. Journal of Immunology 180, 8369-8377.
19. Cirioni, O., Giacometti, A., Ghiselli, R., Orlando, F., Kamysz, W., D'Amato, G., Mocchegiani, F., Lukasiak, J., Silvestri, C., Saba, V. and Scalise, G. (2004) Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. Journal of Infectious Diseases 190, 356-364.
20. Coffelt, S.B., Marini, F.C., Watson, K., Zwezdaryk, K.J., Dembinski, J.L. LaMarca, H.L., Tomchuck, S.L., Honer zu Bentrup, K., Danka, E.S., Henkle, S.L. and Scandurro, A.B. (2009) The proinflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proceedings of the National Academy of Science of the USA 106, 3806-3811.
21. Conlin, V.S., Wu, X., Nguyen, C., Dai, C., Vallance, B., Buchan, M., Boyer, L. and Jacobson, K. (2009) Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 297, G735-G750.
22. Cooper, A., Robinson, S.J., Pickard, C., Jackson, C.L., Friedmann, P.S. and Healy, E. (2005) a-Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte pro lifera tion in humans independently of melanocortin 1 receptor gene status. Journal of Immunology 175, 4806-4813.
23. Coron, E., Flamant, M., Aubert, P., Wedel, T., Pedron, T., Letessier, E., Galmiche, J.P., Sansonetti, P.J. and Neunlist, M. (2009) Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon. PLoS One 4, e4713.
24. Corren, J., Casale, T.B., Lanier, B., Buhl, R., Holgate, S. and Jimenez, P. (2009) Safety and tolerability of omalizumab. Clinical and Experimental Allergy 39, 788-797.
25. Dankesreiter, S., Hoess, A., Schneider-Mergener, J., Wagner, H. and Miethke, T. (2000) Synthetic endotoxin-binding peptides block endotoxintriggered TNF-a production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. Journal of Immunology 164, 4804-4811.
26. Dayan, C.M. and Wraith, D.C. (2008) Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412. Clinical and Experimental Immunology 151, 231-234.
27. Delgado, M., Pozo, D. and Ganea, D. (2004) The significance of vasoactive intestinal peptide in immunomodulation. Pharmacological Reviews 56, 249-290.
28. Del-Rio-Navarro, B.E., Espinosa Rosales, F., Flenady, V. and Sienra-Monge, J.J. (2006) Immunostimulants for preventing respiratory tract infection in children. Cochrane Database of Systematic Reviews 4, CD004974.
29. Di Nardo, A., Vitiello, A. and Gallo, R.L. (2003) Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. Journal of Immunology 170, 2274-2278.
30. Doi, K., Hu, X., Leelahavanichkul, A., Yasuda, H., Schnermann, J. and Nielsen, S. (2008) AP214, an analogue of a-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney International 73, 1266-1274.
31. Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G.H. and Gallo, R.L. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. Journal of Investigative Dermatology 117, 91-97.
32. Dressel, S., Harder, J., Cordes, J., Wittersheim, M., Meyer-Hoffert, U., Sunderkotter, C. and Glaser, R. (2010) Differential expression of antimicrobial peptides in margins of chronic wounds. Experimental Dermatology 19, 628-632.
33. Durr, U.H., Sudheendra, U.S. and Ramamoorthy, A. (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochimica et Biophysica Acta 1758, 1408-1425.
34. Economopoulou, M., Bdeir, K., Cines, D.B., Fogt, F., Bdeir, Y., Lubkowski, J., Lu, W., Preissner, K.T., Hammes, H.P. and Chavakis, T.M. (2005) Inhibition of pathologic retinal neovascularization by a-defensins. Blood 106, 3831-3838.
35. Eleuteri, E. and Di Stefano, A. (2009) Biomarkers in heart failure. Minerva Cardioangiologica Nov 30 [epub ahead of print].
36. Fadnes, B., Rekdal, O. and Uhlin-Hansen, L. (2009) The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells. BMC Cancer 9, 183.
37. Falco, A., Ortega-Villaizan, M., Chico, V., Brocal, I., Perez, L., Coll, J.M. and Estepa, A. (2009) Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture. Mini Reviews in Medicinal Chemistry 9, 1159-1164.
38. Falla, T.J. and Zhang, L. (2010) Efficacy of hexapeptide-7 on menopausal skin. Journal of Drugs in Dermatology 9, 49-54.
39. Feldmann, M. and Steinman, L. (2005) Design of effective immunotherapy for human autoimmunity. Nature 435, 612-619.
40. Fellermann, K., Stange, D.E., Schaeffeler, E., Schmalzl, H., Wehkamp, J., Bevins, C.L., Reinisch, W., Teml, A., Schwab, M., Lichter, P., Radlwimmer, B. and Stange E.F. (2006) A chromosome 8 gene-cluster polymorphism with low human β-defensin 2 gene copy number predisposes to Crohn disease of the colon. American Journal of Human Genetics 79, 439-448.
41. Filewod, N.C., Pistolic, J. and Hancock, R.E. (2009) Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli. FEMS Immunology and Medical Microbiology 56, 233-240.
42. Fischer, P.M. (2003) The design, synthesis and application of stereochemical and directional peptide isomers: a critical review. Current Protein and Peptide Science 4, 339-356.
43. Fjell, C.D., Jenssen, H., Hilpert, K., Cheung, W.A., Pante, N., Hancock, R.E. and Cherkasov, A. (2009) Identification of novel antibacterial peptides by chemoinformatics and machine learning. Journal of Medicinal Chemistry 52, 2006-2015.
44. Gallo, S.A., Wang, W., Rawat, S.S., Jung, G., Waring, A.J., Cole, A.M., Lu, H., Yan, X., Daly, N.L., Craik, D.J, Jiang, S., Lehrer, R.I. and Blumenthal, R. (2006) γ-Defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. Journal of Biological Chemistry 281, 18787-18792.
45. Ganea, D. (1996) Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Advances in Neuroimmunology 6, 61-74.
46. Ganz, T. (2009) Iron in innate immunity: starve the invaders. Current Opinion in Immunology 21, 63-67.
47. Garlapati, S., Facci, M., Polewicz, M., Strom, S., Babiuk, L.A., Mutwiri, G., Hancock, R.E., Elliott, M.R. and Gerdts, V. (2009) Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Veterinary Immunology and Immunopathology 128, 184-191.
48. Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Viticchi, C., Orlando, F., D'Amato, G., Del Prete, M.S., Kamysz, W., lLukasiak, J., Saba, V. and Scalise, G. (2003) Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock. Peptides 24, 1747-1752.
49. Gottlieb, S. (2008) Biosimilars: policy, clinical, and regulatory considerations. American Journal of Health-System Pharmacy 65, S2-S8.
50. Hancock, R.E. and Sahl, H.G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology 24, 1551-1557.
51. Harder, J., Dressel, S., Wittersheim, M., Cordes, J., Meyer-Hoffert, U., Mrowietz, U., Fölster-Holst, R., Proksch, E., Schröder, J.M., Schwarz, T. and Gläser, R. (2010) Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. Journal of Investigative Dermatology 130, 1355-1364.
52. Hirsch, T., Spielmann, M., Zuhaili, B., Fossum, M., Metzig, M., Koehler, T., Steinau, H.U., Yao, F., Onderdonk, A.B., Steinstraesser, L. and Eriksson, E. (2009) Human β-defensin-3 promotes wound healing in infected diabetic wounds. Journal of Gene Medicine 11, 220-228.
53. Holtmann, M.M. (2003) RDP-58 (SangStat Medical). IDrugs 6, 1188-1194.
54. Howell, M.D., Wollenberg, A., Gallo, R.L., Flaig, M., Streib, J.E., Wong, C., Pavicic, T., Boguniewicz, M. and Leung, D.Y. (2006) Cathelicidin deficiency predisposes to eczema herpeticum. Journal of Allergy and Clinical Immunology 117, 836-841.
55. Huang, C., Yuan, M., Huang, H., Wu, G., Liu, Y., Yu, S., Li, H. and Wang, T. (2009) Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30, 2286-2291.
56. Huang, L.C., Reins, R.Y., Gallo, R.L. and McDermott, A.M. (2007) Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Vision Science 48, 4498-4508.
57. Hubert, P., Herman, L., Maillard, C., Caberg, J.H., Nikkels, A., Pierard, G., Foidart, J.M, Noel, A., Boniver, J. and Delvenne, P. (2007) Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre) neoplastic lesions formed in vitro and transplanted in vivo. FASEB Journal 21, 2765-2775.
58. Hurtado, P. and Peh, C.A. (2010) LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells. Journal of Immunology 184, 1425-1435.
59. Iimura, M., Gallo, R.L., Hase, K., Miyamoto, Y., Eckmann, L. and Kagnoff, M.F. (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. Journal of Immunology 174, 4901-4907.
60. Imatani, T., Kato, T., Minaguchi, K. and Okuda, K. (2000) Histatin 5 inhibits inflammatory cytokine induction from human gingival fibroblasts by Porphyromonas gingivalis. Oral Microbiology and Immunology 15, 378-382.
61. Imatani, T., Kato, T., Okuda, K. and Yamashita, Y. (2004) Histatin 5 inhibits apoptosis in human gingival fibroblasts induced by Porphyromonas gingivalis cell-surface polysaccharide. European Journal of Medical Research 9, 528-532.
62. Irwin, D.C., Tissot van Patot, M.C., Tucker, A. and Bowen, R. (2005) Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. American Journal of Physiology-Lung Cellular and Molecular Physiology 288, L849-L859.
63. Jacob, A., Rajan, D., Pathickal, B., Balouch, I., Hartman, A., Wu, R., Zhou, M. and Wang, P. (2010) The inhibitory effect of ghrelin on sepsisinduced inflammation is mediated by the MAPK phosphatase-1. International Journal of Molecular Medicine 25, 159-164.
64. Kalus, A.A., Fredericks, L.P., Hacker, B.M., Dommisch, H., Presland, R.B., Kimball, J.R. and Dale, B.A. (2009) Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple β-defensins in gingival keratinocytes. BMC Oral Health 9, 21.
65. Kandil, E., Burack, J., Sawas, A., Bibawy, H., Schwartzman, A., Zenilman, M.E. and Bluth, M.H. (2008) B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock. Archives of Surgery 143, 242-246.
66. Kim, J.H., Lee, C., Yoon, H.I., Song, J., Shin, W.G. and Lee, J.H. (2010) Relation of ghrelin, leptin and inflammatory markers to nutritional status in active pulmonary tuberculosis. Clinical Nutrition 29, 512-518.
67. Kindrachuk, J., Jenssen, H., Elliott, M., Townsend, R., Nijnik, A., Lee, S.F., Gerdts, V., Babiuk, L.A., Halperin, S.A. and Hancock, R.E. (2009) A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 27, 4662-4471.
68. Kocsis, A.K., Lakatos, P.L., Somogyvári, F., Fuszek, P., Papp, J., Fischer, S., Szamosi, T., Lakatos, L., Kovacs, A., Hofner, P. and Mándi, Y. (2008) Association of β-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scandinavian Journal of Gastroenterology 43, 299-307.
69. Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., Karl, A., Raake, P., Pfosser, A., Boekstegers, P., Welsch, U., Hiemstra, P.S., Vogelmeier, C., Gallo, R. L., Clauss, M. and Bals, R. (2003) An angiogenic role for the human peptide antibiotic LL-37/ hCAP-18. Journal of Clinical Investigation 111, 1665-1672.
70. Kodama, T., Ashitani, J., Matsumoto, N., Kangawa, K. and Nakazato, M. (2008) Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulmonary Pharmacology and Therapeutics 21, 774-779.
71. Kollef, M., Pittet, D., Sánchez-García, M., Chastre, J., Fagon, J.Y., Bonten, M., Hyzy, R., Fleming, T.R., Fuchs, H., Bellm, L., Mercat, A., Mañez, R., Martínez, A., Eggimann, P., Daguerre, M., Luyt, C.E. and Prevention of Pneumonia Study (POPS-1) Trial Group (2006) A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 173, 91-97.
72. Kovacs-Nolan, J., Latimer, L., Landi, A., Jenssen, H., Hancock, R.E., Babiuk, L.A. and van Drunen Littel-van den Hurk, S. (2009a) The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibodyand cell-mediated immune responses in mice. Vaccine 27, 2055-2064.
73. Kovacs-Nolan, J., Mapletoft, J.W., Latimer, L., Babiuk, L.A. and Hurk, S.D. (2009b) CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 27, 2048-2054.
74. Kovacs-Nolan, J., Mapletoft, J.W., Lawman, Z., Babiuk, L.A. and van Drunen Littel-van den Hurk, S. (2009c) Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice. Journal of General Virology 90, 1892-1905.
75. Kraus, D. and Peschel, A. (2008) Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiology 3, 437-451.
76. Krylov, A.V., Kisseleva, E.P., Aleshina, G.M., Shamova, O.V. and Kokryakov, V.N. (2007) Effects of defensin and lactoferrin on functional activity of endothelial cells in vitro. Bulletins in Experimental Biological Medicine 144, 331-334.
77. Lau, Y.E., Rozek, A., Scott, M.G., Goosney, D.L., Davidson, D.J. and Hancock, R.E. (2005) Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infection and Immunity 73, 583-591.
78. Lee, P.H., Rudisill, J.A., Lin, K.H., Zhang, L., Harris, S.M., Falla, T.J. and Gallo, R.L. (2004) HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair and Regeneration 12, 351-358.
79. Lillard, J.W. Jr, Boyaka, P.N., Chertov, O., Oppenheim, J.J. and McGhee, J.R. (1999) Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proceedings of the National Academy of Science USA 96, 651-656.
80. Lingnau, K., Egyed, A., Schellack, C., Mattner, F., Buschle, M. and Schmidt, W. (2002) Poly-Larginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of proinflammatory cytokines. Vaccine 20, 3498-3508.
81. Lv, B., Tang, Y., Chen, F. and Xiao, X. (2009) Vasoactive intestinal peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo. Shock 31, 185-191.
82. Mader, J.S. and Hoskin, D.W. (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opinion in Investigational Drugs 15, 933-946.
83. Majchrzykiewicz, J.A., Kuipers, O.P. and Bijlsma, J.J. (2010) Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides: bacitracin, LL-37 and nisin. Antimicrobial Agents and Chemotherapy 54, 440-451.
84. McPhee, J.B., Lewenza, S. and Hancock, R.E. (2003) Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Molecular Microbiology 50, 205-217.
85. Miyoshi, M., Kitagawa, Y., Imoto, T. and Watanabe, T. (2006) Effect of natriuretic peptide receptor antagonist on lipopolysaccharide-induced fever in rats: is natriuretic peptide an endogenous antipyretic?. Journal of Pharmacology and Experimental Therapeutics 318, 1163-1170.
86. Mohapatra, S.S. (2007) Role of natriuretic peptide signaling in modulating asthma and inflammation. Canadian Journal of Physiology and Pharmacology 85, 754-759.
87. Mookherjee, N., Brown, K.L., Bowdish, D.M., Doria, S., Falsafi, R., Hokamp, K., Roche, F.M., Mu, R., Doho, G.H., Pistolic, J., Powers, J.P., Bryan, J., Brinkman, F.S. and Hancock, R.E. (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. Journal of Immunology 176, 2455-2464.
88. Mookherjee, N., Rehaume, L.M. and Hancock, R.E. (2007) Cathelicidins and functional analogues as antisepsis molecules. Expert Opinion in Therapeutic Targets 11, 993-1004.
89. Mookherjee, N., Lippert, D.N., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J., Miri, P., Naseer, M., Foster, L.J, and Hancock, R.E. (2009a) Intracellular receptor for human host defense peptide LL-37 in monocytes. Journal of Immunology 183, 2688-2696.
90. Mookherjee, N., Hamill, P., Gardy, J., Blimkie, D., Falsafi, R., Chikatamarla, A., Arenillas, D.J., Doria, S., Kollmann, T.R. and Hancock, R.E. (2009b) Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Molecular Biosystems 5, 483-496.
91. Murphy, C.J., Foster, B.A., Mannis, M.J., Selsted, M.E. and Reid, T.W. (1993) Defensins are mitogenic for epithelial cells and fibroblasts. Journal of Cellular Physiology 155, 408-413.
92. Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Tanaka, S. and Heumann, D. (2002) Augmentation of the lipopolysaccharideneutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clinical and Diagnostic Laboratory Immunology 9, 972-982.
93. Nell, M.J., Tjabringa, G.S., Wafelman, A.R., Verrijk, R., Hiemstra, P.S., Drijfhout, J.W. and Grote, J.J. (2006) Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27, 649-660.
94. Nemeth, E. (2010) Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Advances in Hematology 2010, 750643.
95. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K. and Ganz, T. (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation 113, 1271-1276.
96. Nicholls, E.F., Madera, L. and Hancock, R.E. (2010) Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Annals of the New York Academy of Sciences (in press).
97. Nijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M.R., Easton, D.M., Mayer, M.L., Mullaly, S.C., Kindrachuk, J., Jenssen, H. and Hancock, R.E. (2010) Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. Journal of Immunology 184, 2539-2550.
98. Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T. and Kaku, T. (2004) Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. Journal of Dermatological Science 36, 87-95.
99. Niyonsaba, F., Ushio, H., Nagaoka, I., Okumura, K. and Ogawa, H. (2005) The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. Journal of Immunology 175, 1776-1784.
100. Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K. and Ogawa, H. (2007) Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. Journal of Investigative Dermatology 127, 594-604.
101. Niyonsaba, F., Suzuki, A., Ushio, H., Nagaoka, I., Ogawa, H. and Okumura, K. (2009) The human antimicrobial peptide dermcidin activates normal human keratinocytes. British Journal of Dermatology 160, 243-249.
102. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., Pestonjamasp, V., Piraino, J., Huttner, K. and Gallo, R.L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
103. Oda, J., Kasai, K., Noborio, M., Aoki, Y., Yamashita, K., Inoue, T., Ueyama, M. and Yukioka, T. (2009) Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock. Journal of Trauma 66, 1281-1285.
104. Ong, P.Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R.L. and Leung, D.Y. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. New England Journal of Medicine 347, 1151-1160.
105. Oppenheim, J.J. and Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Current Opinion in Immunology 17, 359-365.
106. Otte, J.M., Werner, I., Brand, S., Chromik, A.M., Schmitz, F., Kleine, M. and Schmidt, W.E. (2008) Human beta defensin 2 promotes intestinal wound healing in vitro. Journal of Cell Biochemistry 104, 2286-2297.
107. Otte, J.M., Zdebik, A.E., Brand, S., Chromik, A.M., Strauss, S., Schmitz, F., Steinstraesser, L. and Schmidt, W.E. (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regulatory Peptides 156, 104-117.
108. Oudhoff, M.J., Bolscher, J.G., Nazmi, K., Kalay, H., van't Hof, W., Amerongen, A.V. and Veerman, E.C. (2008) Histatins are the major woundclosure stimulating factors in human saliva as identified in a cell culture assay. FASEB Journal 22, 3805-3812.
109. Overhage, J., Campisano, A., Bains, M., Torfs, E.C., Rehm, B.H. and Hancock, R.E. (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infection and Immunity 76, 4176-4182.
110. Park, C.C., Morel, J.C., Amin, M.A., Connors, M.A., Harlow, L.A. and Koch, A.E. (2001) Evidence of IL-18 as a novel angiogenic mediator. Journal of Immunology 167, 1644-1653.
111. Pini, A., Falciani, C., Mantengoli, E., Bindi, S., Brunetti, J., Iozzi, S., Maria Rossolini, G. and Bracci, L. (2009) A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB Journal 24, 1015-1022.
112. Ponce, R. (2008) Adverse consequences of immunostimulation. Journal of Immunotoxicology 5, 33-41.
113. Potter, L.R., Yoder, A.R., Flora, D.R., Antos, L.K. and Dickey, D.M. (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology 341-366.
114. Rivera, S., Nemeth, E., Gabayan, V., Lopez, M.A., Farshidi, D. and Ganz, T. (2005) Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportincontaining organs. Blood 106, 2196-2199.
115. Rodriguez-Garcia, M., Oliva, H., Climent, N., Escribese, M.M., Garcia, F., Moran, T.M., Gatell, J.M. and Gallart, T. (2009) Impact of a-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects. Clinical Immunology 131, 374-384.
116. Rose, R.A. (2010) CD-NP, a chimeric natriuretic peptide for the treatment of heart failure. Current Opinion in Investigational Drugs 11, 349-356.
117. Rudiger, A., Gasser, S., Fischler, M., Hornemann, T., von Eckardstein, A. and Maggiorini, M. (2006) Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Critical Care Medicine 34, 2140-2144.
118. Sarkar, A., Sreenivasan, Y. and Manna, S.K. (2003) a-Melanocyte-stimulating hormone induces cell death in mast cells: involvement of NF-kB. FEBS Letters 549, 87-93.
119. Schaible, U.E. and Kaufmann, S.H. (2004) Iron and microbial infection. Nature Reviews Microbiology 2, 946-953.
120. Schaller-Bals, S., Schulze, A. and Bals, R. (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. American Journal of Respiratory and Critical Care Medicine 165, 992-995.
121. Schellack, C., Prinz, K., Egyed, A., Fritz, J.H., Wittmann, B., Ginzler, M., Swatosch, G., Zauner, W., Kast, C., Akira, S., von Gabain, A., Buschle, M. and Lingnau, K. (2006) IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine 24, 5461-5472.
122. Scholzen, T.E., Sunderkötten, C., Kalden, D.-H., Brzoska, T., Fastrich, M., Fisbeck, T., Armstrong, C.A., Ansel, J.C. and Luger, T.A. (2003) a-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by downregulating endothelial cell adhesion molecule expression. Endocrinology 144, 360-370.
123. Scotland, R.S., Cohen, M., Foster, P., Lovell, M., Mathur, A., Ahluwalia, A. and Hobbs, A.J. (2005) C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proceedings of the National Academy of Sciences of the USA 102, 14452-14457.
124. Scott, M.G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., Yu, J.J., Li, Y., Donini, O., Guarna, M.M., Finlay, B.B, North, J.R. and Hancock, R.E. (2007) An anti-infective peptide that selectively modulates the innate immune response. Nature Biotechnology 25, 465-472.
125. Sekino, M., Makita, T., Ureshino, H., Sungsam, C. and Sumikawa, K. (2010) Synthetic atrial natriuretic peptide improves systemic and splanchnic circulation and has a lung-protective effect during endotoxemia in pigs. Anesthesia and Analgesia 110, 141-147.
126. Selsted, M.E. and Ouellette, A.J. (2005) Mammalian defensins in the antimicrobial immune response. Nature Immunology 6, 551-557.
127. Shuchman, M. (2008) Clinical trials regulation-how Canada compares. Canadian Medical Association Journal 179, 635-638.
128. Singh, S., Nannuru, K.C., Sadanandam, A., Varney, M.L. and Singh, R.K. (2009) CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. British Journal of Cancer 100, 1638-1646.
129. Sokolova, G.B., Sinitsyn, M.V., Kozhemiakin, L.A. and Perel'man, M.I. (2002) Glutoxim in the complex treatment of tuberculosis. Antibiotiki i Khimioterapiia 47, 20-23.
130. Soruri, A., Grigat, J., Forssmann, U., Riggert, J. and Zwirner, J. (2007) β-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. European Journal of Immunology 37, 2474-2486.
131. Sow, F.B., Alvarez, G.R., Gross, R.P., Satoskar, A.R., Schlesinger, L.S., Zwilling, B.S. and Lafuse, W.P. (2009) Role of STAT1, NF-kB, and C/EBPβ in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. Journal of Leukocyte Biology 86, 1247-1258.
132. Steinstraesser, L., Ring, A., Bals, R., Steinau, H.U. and Langer, S. (2006) The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers. Annals of Plastic Surgery 56, 93-98.
133. Steinstraesser, L., Koehler, T., Jacobsen, F., Daigeler, A., Goertz, O., Langer, S., Kesting, M., Steinau, H., Eriksson, E. and Hirsch, T. (2008) Host defense peptides in wound healing. Molecular Medicine 14, 528-537.
134. Steinstraesser, L., Kraneburg, U.M., Hirsch, T., Kesting, M., Steinau, H.U., Jacobsen, F. and Al-Benna, S. (2009) Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?. International Journal of Molecular Science 10, 3951-3970.
135. Suntharalingam, G., Perry, M.R., Ward, S., Brett, S.J., Castello-Cortes, A., Brunner, M.D. and Panoskaltsis, N. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New England Journal of Medicine 355, 1018-1028.
136. Suttmann, H., Retz, M., Paulsen, F., Harder, J., Zwergel, U., Kamradt, J., Wullich, B., Unteregger, G., Stöckle, M. and Lehmann, J. (2008) Antimicrobial peptides of the cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urology 8, 5.
137. Szliter, E.A., Lighvani, S., Barrett, R.P. and Hazlett, L.D. (2007) Vasoactive intestinal peptide balances pro-and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. Journal of Immunology 178, 1105-1114.
138. Tai, E.K., Wu, W.K., Wong, H.P., Lam, E.K., Yu, L. and Cho, C.H. (2007) A new role for cathelicidin in ulcerative colitis in mice. Experimental Biological Medicine 232, 799-808.
139. Tang, Y.Q., Yuan, J., Osapay, G., Osapay, K., Tran, D., Miller, C.J., Ouellette, A.J. and Selsted, M.E. (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated a-defensins. Science 286, 498-502.
140. Tani, K., Murphy, W.J., Chertov, O., Salcedo, R., Koh, C.Y., Utsunomiya, I., Funakoshi, S., Asai, O., Herrmann, S.H., Wang, J.M., Kwak, L.W., and Oppenheim, J.J. (2000) Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. International Immunology 12, 691-700.
141. Tjabringa, G.S., Aarbiou, J., Ninaber, D.K., Drijfhout, J.W., Sorensen, O.E., Borregaard, N., Rabe, K.F. and Hiemstra, P.S. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. Journal of Immunology 171, 6690-6696.
142. Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., Tossi, A., Di Virgilio, F. and Zanetti, M. (2008) The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. Journal of Biological Chemistry 283, 30471-30481.
143. Travis, S., Yap, L.M., Hawkey, C., Warren, B., Lazarov, M., Fong, T. and Tesi, R.J. (2005) RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflammatory Bowel Disease 11, 713-719.
144. van den Berg, H.R., Khan, N.A., van der Zee, M., Bonthuis, F., IJzermans, J.N., Dik, W.A., de Bruin, R.W. and Benner, R. (2009) Synthetic oligopeptides related to the β-subunit of human chorionic gonadotropin attenuate inflammation and liver damage after (trauma) hemorrhagic shock and resuscitation. Shock 31, 285-291.
145. van der Does, A.M., Bogaards, S.J., Ravensbergen, B., Beekhuizen, H., van Dissel, J.T. and Nibbering, P.H. (2010) Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrobial Agents and Chemotherapy 54, 811-816.
146. Vesely, D.L. and de Bold, A.J. (2009) Cardiac natriuretic peptides gene expression and secretion in inflammation. Journal of Investigative Medicine 57, 29-32.
147. Vila, G., Resl, M., Stelzeneder, D., Struck, J., Maier, C., Riedl, M., Hülsmann, M., Pacher, R., Luger, A. and Clodi, M. (2008) Plasma NT-proBNP increases in response to LPS administration in healthy men. Journal of Applied Physiology 105, 1741-1745.
148. von Haussen, J., Koczulla, R., Shaykhiev, R., Herr, C., Pinkenburg, O., Reimer, D., Wiewrodt, R., Biesterfeld, S., Aigner, A., Czubayko, F. and Bals, R. (2008) The host defence peptide LL-37/ hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 59, 12-23.
149. Vonk, M.J., Hiemstra, P.S. and Grote, J.J. (2008) An antimicrobial peptide modulates epithelial responses to bacterial products. The Laryngoscope 118, 816-820.
150. Waldmann, T.A. (2003) Immunotherapy: past, present and future. Nature Medicine 9, 269-277.
151. Wang, L., Harrington, L., Trebicka, E., Shi, H.N., Kagan, J.C., Hong, C.C., Lin, H.Y., Babitt, J.L. and Cherayil, B.J. (2009) Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. Journal of Clinical Investigation 119, 3322-3328.
152. Wang, W., Bansal, S., Falk, S., Ljubanovic, D. and Schrier, R. (2009) Ghrelin protects mice against endotoxemia-induced acute kidney injury. American Journal of Physiology-Renal Physiology 297, F1032-F1037.
153. Wang, X., Xu, W., Kong, X., Chen, D., Hellermann, G., Ahlert, T.A., Giaimo, J.D., Cormier, S.A., Li, X., Lockey, R.F., Mohapatra, S. and Mohapatra, S.S. (2009) Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respiratory Research 10, 66.
154. Warner, D.M. and Levy, S.B. (2010) Different effects of transcriptional regulators MarA, SoxS, and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Robdependent CAMP induction of the marRAB operon. Microbiology 156, 570-578.
155. Weber, G., Chamorro, C.I., Granath, F., Liljegren, A., Zreika, S., Saidak, Z., Sandstedt, B., Rotstein, S., Mentaverri, R., Sánchez, F., Pivarcsi, A. and Ståhle, M. (2009) Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Research 11, R6.
156. World Health Organization (WHO) (2008) World Health Statistics 2008. WHO Press, Geneva, Switzerland. Available at: www.who.int/whosis/ whostat/2008/en/index.html.
157. Wu, R., Zhou, M., Dong, W., Ji, Y., Miksa, M., Marini, C.P., Ravikumar, T.S. and Wang, P. (2009) Ghrelin hyporesponsiveness contributes to agerelated hyperinflammation in septic shock. Annals of Surgery 250, 126-133.
158. Xavier, R.J. and Podolsky, D.K. (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
159. Xing, J. and Birukova, A. (2009) ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFa. Microvascular Research 79, 56-62.
160. Yang, D., Chertov, O., Bykovskaia, S.N., Chen, Q., Buffo, M.J., Shogan, J., Anderson, M., Schröder, J.M., Wang, J.M., Howard, O.M. and Oppenheim, J.J. (1999) β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528.
161. Yoon, S., Goh, S., Chun, J., Cho, E., Lee, M., Kim, K., Kim, J., Kim, C. and Poo, H. (2003) a-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-a production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kB signaling pathways. Journal of Biological Chemistry 278, 32914-32920.
162. Yoon, S.W., Chun, J.S., Sung, M.H., Kim, J.Y. and Poo, H. (2008) a-MSH inhibits TNF-a-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor kB signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis and Cartilage 16, 115-124.
163. Yu, H.B., Kielczewska, A., Rozek, A., Takenaka, S., Li, Y., Thorson, L., Hancock, R.E., Guarna, M.M., North, J.R., Foster, L.J., Donini, O. and Finlay, B.B. (2009) Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. Journal of Biological Chemistry 284, 36007-36011.
164. Yu, J., Mookherjee, N., Wee, K., Bowdish, D.M., Pistolic, J., Li, Y., Rehaume, L. and Hancock, R.E. (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways. Journal of Immunology 179, 7684-7691.
165. Zhang, Z., Cherryholmes, G., Chang, F., Rose, D.M., Schraufstatter, I. and Shively, J.E. (2009) Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. European Journal of Immunology 39, 3181-3194.
166. Zou, L., Sato, N. and Kone, B.C. (2004) Alphamelanocyte stimulating hormone protects against H2O2-induced inhibition of wound restitution in IEC-6 cells via a Syk kinase-and NF-kB-dependent mechanism. Shock 22, 453-459.